Key result
CEUS safely evaluates vasa vasorum in carotid plaque but requires further clinical validation.
Why the study?
The clinical utility of contrast-enhanced ultrasound for evaluating the vasa vasorum in carotid artery plaque requires further assessment to fully establish its role in plaque vulnerability evaluation.
Contrast-enhanced ultrasound is highlighted as a novel and safe imaging modality for evaluating the vasa vasorum in carotid artery plaque, a marker of plaque vulnerability.
May identify vulnerable carotid plaques via CEUS; hypothesis-generating and requires prospective validation before clinical adoption.
The vasa vasorum of carotid artery plaque is a novel marker of accurately evaluating the vulnerability of carotid artery plaque, which was associated with symptomatic cerebrovascular and cardiovascular disease. The presence of ultrasound contrast agents in carotid artery plaque represents the presence of the vasa vasorum in carotid artery plaque because the ultrasound contrast agents are strict intravascular tracers. Therefore, contrast-enhanced ultrasound (CEUS) is a novel and safe imaging modality for evaluating the vasa vasorum in carotid artery plaque. However, there are some issues that needs to be assessed to embody fully the clinical utility of the vasa vasorum in carotid artery plaque with CEUS.
No takes yet. Share an insight, caveat, or question.
Ze–Zhou Song (2015) conducted a review in Carotid artery plaque. Contrast-enhanced ultrasound (CEUS) was evaluated. Contrast-enhanced ultrasound (CEUS) serves as a novel and safe imaging modality for evaluating the vasa vasorum in carotid artery plaque, though further assessment of its clinical utility is needed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: